Skip to main content
Livermore
Livermore
ZHEN

Biomerica Inc

BMRA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0000073290

In the last 90 days, Biomerica Inc insiders filed 5 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $220.0K in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Biomerica Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
5 filings
5 insiders, $158.0K in total
Open-market sells
0 filings
Insiders trading
5
Net value
+$158.0K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Biomerica Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Biomerica Inc
NameTitleLast reported holdingLast filingFilings, past year
Gary M. HuffDirector51,250Aug 27, 20262
Moatazedi DavidDirector40,625Aug 27, 20262
Chin EricDirector38,750Aug 27, 20262
Barbieri AllenExecutive Vice Chairman73,542Aug 27, 20262
Irani Zackary S.Chief Executive Officer242,570Aug 27, 20262
Lu GaryChief Financial Officer59,375Dec 31, 20251
Emerson JaneDirector156,000Dec 17, 20240
Coste CatherineDirector128,790Dec 17, 20240
Kenny John P.Director–Dec 14, 20230
Sirgo Mark ADirector–Dec 10, 20210
Sloan StevenChief Financial Officer–Dec 10, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 25, 2023 (view filing)Jan 241 dayIrani Zackary S.Chief Executive OfficerPPurchase+2.00K$2.81+$5.62K+0.2%1.00M after
Jan 26, 2023 (view filing)Jan 251 dayIrani Zackary S.Chief Executive OfficerPPurchase+1.80K$2.85+$5.13K+0.2%1.01M after
Jan 30, 2023 (view filing)Jan 264 daysCoste CatherineDirector, Other: Audit Committee ChairpersonPPurchase+2.19K$2.96+$6.48K+5.3%43.8K after
Jan 31, 2023 (view filing)Jan 274 daysBarbieri AllenExecutive Vice ChairmanPPurchase+1.54K$2.94+$4.52K+1.5%101.3K after
Apr 27, 2023 (view filing)Apr 261 dayIrani Zackary S.Chief Executive OfficerPPurchase+7.00K$1.26+$8.82K+0.7%1.01M after
May 1, 2023 (view filing)Apr 27-284 daysIrani Zackary S.Chief Executive OfficerPPurchase+4.40K$1.32+$5.82K+0.4%1.02M after2 lots
May 5, 2023 (view filing)May 41 dayIrani Zackary S.Chief Executive OfficerPPurchase+1.00K$1.36+$1.36K+0.1%1.02M after
May 10, 2023 (view filing)May 91 dayIrani Zackary S.Chief Executive OfficerPPurchase+300$1.39+$4170.0%1.02M after
May 12, 2023 (view filing)May 102 daysIrani Zackary S.Chief Executive OfficerPPurchase+500$1.27+$6350.0%1.02M after
May 12, 2023 (view filing)May 12Same dayIrani Zackary S.Chief Executive OfficerPPurchase+1.70K$1.17+$1.99K+0.2%1.02M after
May 26, 2023 (view filing)May 24-252 daysIrani Zackary S.Chief Executive OfficerPPurchase+700$1.59+$1.11K+0.1%1.02M after2 lots
Aug 27, 2026 (view filing)5:23 PM ETAug 261 dayIrani Zackary S.Chief Executive OfficerPPurchase+31.3K$1.60+$50.0K+14.8%242.6K after
Aug 27, 2026 (view filing)5:24 PM ETAug 261 dayBarbieri AllenExecutive Vice ChairmanPPurchase+20.0K$1.60+$32.0K+37.4%73.5K after
Aug 27, 2026 (view filing)5:26 PM ETAug 261 dayChin EricDirectorPPurchase+6.25K$1.60+$10.0K+19.2%38.8K after
Aug 27, 2026 (view filing)5:26 PM ETAug 261 dayMoatazedi DavidDirectorPPurchase+10.0K$1.60+$16.0K+32.7%40.6K after
Aug 27, 2026 (view filing)5:27 PM ETAug 207 daysLateGary M. HuffDirectorPPurchase+31.3K$1.60+$50.0K+156.3%51.3K after